GRF treatment of late pregnant ewes alters maternal and fetal somatotropic axis activity

Autor: G. Kann, R. Garcia-Villar, C. G. Goodyer, B. Barenton, Pierre-Louis Toutain, J. Charrier, Monique Blanchard, Alain Bousquet-Mélou
Přispěvatelé: Bousquet-Mélou, Alain, Physiologie et Toxicologie Expérimentales, Ecole Nationale Vétérinaire de Toulouse (ENVT), Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Recherche Agronomique (INRA), Institut National de la Recherche Agronomique (INRA)-Ecole Nationale Vétérinaire de Toulouse (ENVT), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées
Jazyk: angličtina
Rok vydání: 1991
Předmět:
Physiology
Endocrinology
Diabetes and Metabolism

MESH: Somatostatin
MESH: Insulin-Like Growth Factor I
Growth Hormone-Releasing Hormone
MESH: Insulin-Like Growth Factor II
0302 clinical medicine
MESH: Pregnancy
Pregnancy
Reference Values
MESH: Gestational Age
MESH: Growth Hormone-Releasing Hormone
MESH: Animals
Placental lactogen
Insulin-Like Growth Factor I
0303 health sciences
MESH: Reference Values
MESH: Pregnancy
Animal

Fetal Blood
Somatomedin
3. Good health
GH
Somatostatin
[SDV.SP.PHARMA] Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology
Gestation
Female
medicine.medical_specialty
INSULINE LIKE GROWTH FACTOR
Somatotropic cell
MESH: Sheep
030209 endocrinology & metabolism
Gestational Age
Biology
IGFII
03 medical and health sciences
Fetus
Insulin-Like Growth Factor II
Physiology (medical)
Internal medicine
medicine
Endocrine system
Animals
MESH: Fetal Blood
IGFI
030304 developmental biology
Sheep
MESH: Fetus
medicine.disease
Endocrinology
Growth Hormone
MESH: Growth Hormone
[SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology
Pregnancy
Animal

STH
MESH: Female
Zdroj: American Journal of Physiology
American Journal of Physiology, American Physiological Society, 1991, 260 (4 Pt 1), pp.E575-80
Scopus-Elsevier
ISSN: 0002-9513
Popis: International audience; To examine the effects of anabolic agents given during late gestation on the maternal and fetal somatotropic axes, we injected pregnant ewes twice daily with 0.15 mg somatocrinin (GRF)-(1-29) for 10 days beginning on day 130 of gestation. Maternal and fetal endocrine changes were compared with control animals using both in vivo and in vitro approaches. Treatment with GRF increased maternal plasma levels of growth hormone (GH) and insulin-like growth factor I (IGF-I;P less than 0.05) but not IGF-II. Under in vitro test conditions, maternal pituitary cells showed a greater maximal response (P less than 0.001) to GRF. In the fetuses of treated ewes, cord plasma GH levels were not significantly increased compared with controls. These animals had similar IGF-I but higher IGF-II (P less than 0.05) plasma levels. The maximal response of fetal pituitary cells to GRF was increased (P less than 0.001). GRF treatment had no influence on maternal and fetal pituitary cell responses to somatostatin under either basal or GRF-stimulated conditions. In addition, these treatments did not affect plasma levels of placental lactogen, glucose, or free fatty acids in the maternal and fetal sheep. These data are compatible with the hypothesis that treatment of pregnant ewes in the last days of gestation with GRF could support accelerated fetal growth.
Databáze: OpenAIRE